SYNthesis Research is a small molecule drug discovery company focussing on both early-stage deal flow and strategic longer-term clinical development programs. Headquartered in Melbourne Australia, SYNthesis Research maximises the benefits of the favourable Australian R&D environment to progress its Drug Discovery & Development portfolio. It does this by leveraging its exceptional Innovation Network - An integrated, federated Australian-Chinese R&D network optimised to provide non-dilutive R&D services to the company’s programs, at costs up-to 60% lower than other global locations.